24
Oct
2023

Seqens

Exhibitor at CPHI Barcelona 2023 stand 7C30, API
About Us

SEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong industrial network, 10 R&D centers and 3,500 employees in 9 countries. As an integrated player across the value chain - from raw materials to active ingredients and from research and development to industrialization - SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • FR
  • 2017
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Generic APIs producer
Intermediates Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 7C30, API

Products Featured at CPHI Barcelona 2023

  • Active Pharmaceutical Ingredients

    Product Active Pharmaceutical Ingredients

    SEQENS CDMO is a global leader on the production of Active Pharmaceutical Ingredients. The company has over 25 years of experience in developing and producing high-quality Active Pharmaceutical Ingredients using first class R&D and proprietary technology such as biocatalysis to develop unique proces...
  • Custom Development & Manufacturing

    Product Custom Development & Manufacturing

    Contract Research & Manufacturing Services:Full service from Preclinical to Industrial API Production
  • Drug Delivery Solutions

    Product Drug Delivery Solutions

    CUSTOM MATERIAL FOR DRUG DELIVERY, MEDICAL MATERIALS & BIOMEDICAL APPLICATIONS
  • Paracetamol

    Product Paracetamol

    SEQENS offers wide range of products which includes paracetamol. Contact us for more information.
  • Expansorb

    Product Expansorb

    Poly(lactic acid co-glycolic acid) and poly(caprolactone) copolymers used as functional excipients for controlled and slow drug release (weeks to months) with a single injection.